Sorafenib: In Hepatocellular Carcinoma

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.2, 2008-01, pp. : 251-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selection of Patients with Hepatocellular Carcinoma for Sorafenib

By Abou-Alfa Ghassan K.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 4, 2009-04 ,pp. : 397-403

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma

By Ahn Hee

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1768-1772

Springer Publishing Company

Access to resources Recommend Favorite

Sorafenib: activity and clinical application in patients with hepatocellular carcinoma

By Guan Yong-Song He Qing

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 303-313

Informa Healthcare

Access to resources Recommend Favorite

Sorafenib: A Review of its Use in Advanced Hepatocellular Carcinoma

By Keating Gillian M.

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 223-240

Adis International

Access to resources Recommend Favorite

Sorafenib: a guide to its use in advanced hepatocellular carcinoma

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 10, 2009-10 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite